FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178498985> ?p ?o ?g. }

• W3178498985 endingPage "826" @default.
• W3178498985 startingPage "818" @default.
• W3178498985 abstract "18F-Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a well-established imaging modality to assess responses in patients with B-cell neoplasms. However, there is limited information about the utility of FDG PET/CT after chimeric antigen receptor T-cell (CART) therapies for large B-cell lymphomas. In this retrospective analysis, we aimed to evaluate how FDG PET/CT performs in patients receiving commercially available anti-CD19 CART therapies for relapsed/refractory (r/r) large B-cell lymphomas. In addition, we examined the time to repeat scan and the rate of pseudoprogression within this population. Lastly, the rates of radiographic response to CART therapy using FDG PET/CT are reported.The pre-treatment and post-treatment scans were analyzed from a selected cohort of 43 patients from a single institution. Patients were stratified by diagnosis of either a first occurrence of diffuse large B-cell lymphoma: de novo diffuse large B-cell lymphoma (DLBCL); or a transformed diffuse large B-cell lymphoma arising from indolent non-Hodgkin lymphoma (t-iNHL).More patients received CART therapy for DLBCL than t-iNHL (65 % vs 35 %). FDG PET/CT had a 99 % sensitivity and 100 % specificity for detecting recurrent disease in this group. The median time to initial response assessment was 86 days (IQR 79-91; full range 24-146) after infusion. There were no biopsy-proven cases of pseudoprogression identified. In this selected group of patients, the overall response rate by Lugano 2014 criteria was 56 %. All patients with a partial response (N = 6) eventually progressed despite additional therapy.Due to its excellent test characteristics and ability to detect asymptomatic disease, routine surveillance with PET/CT at 3 months after CART infusion is supported by our data. Earlier PET/CT may be of value in select situations as we did not find any cases of pseudoprogression." @default.
• W3178498985 created "2021-07-19" @default.
• W3178498985 creator A5005058090 @default.
• W3178498985 creator A5015896987 @default.
• W3178498985 creator A5034653699 @default.
• W3178498985 creator A5035265181 @default.
• W3178498985 creator A5061963134 @default.
• W3178498985 creator A5066628879 @default.
• W3178498985 creator A5070683930 @default.
• W3178498985 creator A5075190622 @default.
• W3178498985 creator A5088286702 @default.
• W3178498985 creator A5088355904 @default.
• W3178498985 creator A5089634995 @default.
• W3178498985 creator A5051620306 @default.
• W3178498985 date "2021-07-06" @default.
• W3178498985 modified "2023-10-14" @default.
• W3178498985 title "18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Following Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma" @default.
• W3178498985 cites W1619537825 @default.
• W3178498985 cites W1903017334 @default.
• W3178498985 cites W2016397257 @default.
• W3178498985 cites W2046255925 @default.
• W3178498985 cites W2101571970 @default.
• W3178498985 cites W2116294985 @default.
• W3178498985 cites W2119147717 @default.
• W3178498985 cites W2503407514 @default.
• W3178498985 cites W2504729294 @default.
• W3178498985 cites W2529907518 @default.
• W3178498985 cites W2589417329 @default.
• W3178498985 cites W2593200566 @default.
• W3178498985 cites W2598700764 @default.
• W3178498985 cites W2618943818 @default.
• W3178498985 cites W2773804840 @default.
• W3178498985 cites W2775369717 @default.
• W3178498985 cites W2791969625 @default.
• W3178498985 cites W2806832126 @default.
• W3178498985 cites W2808166290 @default.
• W3178498985 cites W2895608724 @default.
• W3178498985 cites W2898897653 @default.
• W3178498985 cites W2903062212 @default.
• W3178498985 cites W2903225254 @default.
• W3178498985 cites W2905654445 @default.
• W3178498985 cites W2952696872 @default.
• W3178498985 cites W2955322198 @default.
• W3178498985 cites W2960543051 @default.
• W3178498985 cites W2969216121 @default.
• W3178498985 cites W2977459329 @default.
• W3178498985 cites W2981134427 @default.
• W3178498985 cites W2986196170 @default.
• W3178498985 cites W2986629061 @default.
• W3178498985 cites W2992738455 @default.
• W3178498985 cites W3082855561 @default.
• W3178498985 cites W4294138012 @default.
• W3178498985 doi "https://doi.org/10.1007/s11307-021-01627-8" @default.
• W3178498985 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8578305" @default.
• W3178498985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34231105" @default.
• W3178498985 hasPublicationYear "2021" @default.
• W3178498985 type Work @default.
• W3178498985 sameAs 3178498985 @default.
• W3178498985 citedByCount "5" @default.
• W3178498985 countsByYear W31784989852021 @default.
• W3178498985 countsByYear W31784989852022 @default.
• W3178498985 countsByYear W31784989852023 @default.
• W3178498985 crossrefType "journal-article" @default.
• W3178498985 hasAuthorship W3178498985A5005058090 @default.
• W3178498985 hasAuthorship W3178498985A5015896987 @default.
• W3178498985 hasAuthorship W3178498985A5034653699 @default.
• W3178498985 hasAuthorship W3178498985A5035265181 @default.
• W3178498985 hasAuthorship W3178498985A5051620306 @default.
• W3178498985 hasAuthorship W3178498985A5061963134 @default.
• W3178498985 hasAuthorship W3178498985A5066628879 @default.
• W3178498985 hasAuthorship W3178498985A5070683930 @default.
• W3178498985 hasAuthorship W3178498985A5075190622 @default.
• W3178498985 hasAuthorship W3178498985A5088286702 @default.
• W3178498985 hasAuthorship W3178498985A5088355904 @default.
• W3178498985 hasAuthorship W3178498985A5089634995 @default.
• W3178498985 hasBestOaLocation W31784989852 @default.
• W3178498985 hasConcept C126322002 @default.
• W3178498985 hasConcept C126838900 @default.
• W3178498985 hasConcept C2775842073 @default.
• W3178498985 hasConcept C2777415128 @default.
• W3178498985 hasConcept C2778559949 @default.
• W3178498985 hasConcept C2779338263 @default.
• W3178498985 hasConcept C2989005 @default.
• W3178498985 hasConcept C71924100 @default.
• W3178498985 hasConceptScore W3178498985C126322002 @default.
• W3178498985 hasConceptScore W3178498985C126838900 @default.
• W3178498985 hasConceptScore W3178498985C2775842073 @default.
• W3178498985 hasConceptScore W3178498985C2777415128 @default.
• W3178498985 hasConceptScore W3178498985C2778559949 @default.
• W3178498985 hasConceptScore W3178498985C2779338263 @default.
• W3178498985 hasConceptScore W3178498985C2989005 @default.
• W3178498985 hasConceptScore W3178498985C71924100 @default.
• W3178498985 hasFunder F4320306133 @default.
• W3178498985 hasFunder F4320337349 @default.
• W3178498985 hasIssue "6" @default.
• W3178498985 hasLocation W31784989851 @default.
• W3178498985 hasLocation W31784989852 @default.
• W3178498985 hasLocation W31784989853 @default.

• next